Although polyenes were the first broad spectrum antifungal drugs on the market, after 70
years they are still the gold standard to treat a variety of fungal infections. Polyenes such as …

We checked all papers published along the last 10 years describing epidemiological,
diagnostic, and clinical aspects of infections by MDR Candida spp., with emphasis on C …

Candida auris and C. haemulonii are closely related, multidrug-resistant emerging fungal
pathogens that are not readily distinguishable with phenotypic assays. We studied C. auris …

Candida auris is an emerging multidrug-resistant yeast that has been systematically
incorrectly identified by phenotypic methods in clinical microbiology laboratories. The Vitek 2 …

There is worldwide concern about the constant increase in infections caused by Candida
species that are multiresistant to antifungal drugs. The most common candidiasis is caused …

Although considered rare, the emergent Candida haemulonii species complex, formed by C.
haemulonii sensu stricto (Ch), C. duobushaemulonii (Cd) and C. haemulonii var. vulnera …

Candida haemulonii species complex (CHSC) are emerging multidrug-resistant yeast
pathogens able to cause life-threatening human infections in at-risk populations for invasive …

This study aimed to evaluate the frequency of cryptic Candida species from candidemia
cases in 22 public hospitals in São Paulo State, Brazil, and their antifungal susceptibility …

Candida auris is considered a public health problem because of its resistance and its
tendency to cause nosocomial outbreaks. CHROMagarTM Candida Plus has recently been …

Candida haemulonii complex (Candida haemulonii, Candida haemulonii var. vulnera, and
Candida duobushaemulonii) consists of emerging pathogens. Thirty-one isolates from 14 …